Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer.

Emerson RO, Sherwood AM, Rieder MJ, Guenthoer J, Williamson DW, Carlson CS, Drescher CW, Tewari M, Bielas JH, Robins HS.

J Pathol. 2013 Dec;231(4):433-440. doi: 10.1002/path.4260.

2.

Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas.

Gerlinger M, Quezada SA, Peggs KS, Furness AJ, Fisher R, Marafioti T, Shende VH, McGranahan N, Rowan AJ, Hazell S, Hamm D, Robins HS, Pickering L, Gore M, Nicol DL, Larkin J, Swanton C.

J Pathol. 2013 Dec;231(4):424-32. doi: 10.1002/path.4284.

3.

T cell receptor β-chain repertoire analysis reveals intratumour heterogeneity of tumour-infiltrating lymphocytes in oesophageal squamous cell carcinoma.

Chen Z, Zhang C, Pan Y, Xu R, Xu C, Chen Z, Lu Z, Ke Y.

J Pathol. 2016 Aug;239(4):450-8. doi: 10.1002/path.4742. Epub 2016 Jul 5.

PMID:
27171315
4.

Characterization of the T-cell receptor beta chain repertoire in tumor-infiltrating lymphocytes.

Nakanishi K, Kukita Y, Segawa H, Inoue N, Ohue M, Kato K.

Cancer Med. 2016 Sep;5(9):2513-21. doi: 10.1002/cam4.828. Epub 2016 Jul 27.

5.

T cell receptor β-chain repertoire analysis reveals the association between neoantigens and tumour-infiltrating lymphocytes in multifocal papillary thyroid carcinoma.

Lu Z, Zhang C, Sheng J, Shen J, Liu B.

Int J Cancer. 2017 Jul 15;141(2):377-382. doi: 10.1002/ijc.30743. Epub 2017 May 10.

PMID:
28431188
6.

T-cell receptor repertoire in tumor-infiltrating lymphocytes. Analysis of melanoma-specific long-term lines.

Nishimura MI, Kawakami Y, Charmley P, O'Neil B, Shilyansky J, Yannelli JR, Rosenberg SA, Hood L.

J Immunother Emphasis Tumor Immunol. 1994 Aug;16(2):85-94.

PMID:
7804531
7.

Heterogeneous expansion of CD4+ tumor-infiltrating T-lymphocytes in clear cell renal cell carcinomas.

Zhang Q, Jia Q, Deng T, Song B, Li L.

Biochem Biophys Res Commun. 2015 Feb 27;458(1):70-6. doi: 10.1016/j.bbrc.2015.01.069. Epub 2015 Jan 28.

PMID:
25637538
8.

Digital genomic quantification of tumor-infiltrating lymphocytes.

Robins HS, Ericson NG, Guenthoer J, O'Briant KC, Tewari M, Drescher CW, Bielas JH.

Sci Transl Med. 2013 Dec 4;5(214):214ra169. doi: 10.1126/scitranslmed.3007247.

9.

Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy.

Page DB, Yuan J, Redmond D, Wen YH, Durack JC, Emerson R, Solomon S, Dong Z, Wong P, Comstock C, Diab A, Sung J, Maybody M, Morris E, Brogi E, Morrow M, Sacchini V, Elemento O, Robins H, Patil S, Allison JP, Wolchok JD, Hudis C, Norton L, McArthur HL.

Cancer Immunol Res. 2016 Oct;4(10):835-844. Epub 2016 Sep 1. Erratum in: Cancer Immunol Res. 2017 Mar;5(3):269.

10.

Multi-omics study revealing the complexity and spatial heterogeneity of tumor-infiltrating lymphocytes in primary liver carcinoma.

Shi L, Zhang Y, Feng L, Wang L, Rong W, Wu F, Wu J, Zhang K, Cheng S.

Oncotarget. 2017 May 23;8(21):34844-34857. doi: 10.18632/oncotarget.16758.

11.

Characterization of T-cell receptor V beta repertoire in ovarian tumour-reacting CD3+ CD8+ CD4- CTL lines.

Fisk B, Flytzanis CN, Pollack MS, Wharton JT, Ioannides CG.

Scand J Immunol. 1994 Dec;40(6):591-600. Erratum in: Scand J Immunol 1995 Jan;41(1):102. Flytzanes CN [corrected to Flytzanis CN].

PMID:
7848491
12.

Annotation of pseudogenic gene segments by massively parallel sequencing of rearranged lymphocyte receptor loci.

Dean J, Emerson RO, Vignali M, Sherwood AM, Rieder MJ, Carlson CS, Robins HS.

Genome Med. 2015 Nov 23;7:123. doi: 10.1186/s13073-015-0238-z.

13.

T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.

Peoples GE, Davey MP, Goedegebuure PS, Schoof DD, Eberlein TJ.

J Immunol. 1993 Nov 15;151(10):5472-80.

PMID:
8228239
15.

The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.

Weidmann E, Whiteside TL, Giorda R, Herberman RB, Trucco M.

Cancer Res. 1992 Nov 1;52(21):5913-20.

16.

Cytotoxic T lymphocytes directed against a tumor-specific mutated antigen display similar HLA tetramer binding but distinct functional avidity and tissue distribution.

Echchakir H, Dorothée G, Vergnon I, Menez J, Chouaib S, Mami-Chouaib F.

Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9358-63. Epub 2002 Jul 1.

17.

Immune DNA signature of T-cell infiltration in breast tumor exomes.

Levy E, Marty R, Gárate Calderón V, Woo B, Dow M, Armisen R, Carter H, Harismendy O.

Sci Rep. 2016 Jul 25;6:30064. doi: 10.1038/srep30064.

18.

Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.

Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.

Clin Cancer Res. 2000 Jun;6(6):2268-78.

20.

Evidence for existence of oligoclonal tumor-infiltrating lymphocytes and predominant production of T helper 1/T cytotoxic 1 type cytokines in gastric and colorectal tumors.

Matsutani T, Shiiba K, Yoshioka T, Tsuruta Y, Suzuki R, Ochi T, Itoh T, Musha H, Mizoi T, Sasaki I.

Int J Oncol. 2004 Jul;25(1):133-41.

PMID:
15201998

Supplemental Content

Support Center